2024 Annual Meeting | C116 - Clinical Approach to Sleep Disorders

Date Tuesday 04/16/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | Mile High 1EF

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Logan D. Schneider, MD

Topic(s) Sleep

Learning Objectives Participants should become familiar with healthy (vs not) sleep patterns and how to easily identify them and provide guidance on achieving them for patients in major epochs of life: childhood, midlife, late life.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM MDT	Introduction	Introduction Logan D. Schneider, MD
01:05 PM - 01:40 PM MDT	Speaker	Sleep & Neurological Health in Youth Anne M. Morse, DO
01:40 PM - 02:15 PM MDT	Speaker	Midlife Sleep Health: From the Perspective of Disruptive Sleep Schedules Logan D. Schneider, MD
02:15 PM - 02:50 PM MDT	Speaker	Keeping the Brain Young with Sleep Karin G. Johnson, MD, FAAN
02:50 PM - 03:00 PM MDT	Q&A	Questions & Answers Logan D. Schneider, MD, Anne M. Morse, DO, Karin G. Johnson, MD, FAAN

Faculty Disclosures
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Anne M. Morse, DO	Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes. Dr. Morse has received personal compensation in the range of $0-$499 for serving as a Consultant for NLS Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Avadel. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Hayes solicitors. Dr. Morse has received publishing royalties from a publication relating to health care. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with DAMM Good Sleep, LLC.
Karin G. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Save Standard Time. The institution of Dr. Johnson has received research support from Avadel. The institution of Dr. Johnson has received research support from Apnimed.